1008-16: Treating Opioid Use Disorder During the Current Epidemic

The purpose of this activity is to empower nurses to provide and/or support patient access to evidence-based treatments for opioid use disorders.

Presenter: Matthew Tierney, APN-BC, PMHNP-BC

Disclosures: The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label uses will be discussed during this presentation.

Session Length:  90 minutes

Target Audience:  RN, APRN

Session Objectives:
Upon completion of this presentation, the participant will be able to:
1. Summarize epidemiologic research details on current rates of opioid use, related morbidity and mortality, and impediments to treatment.
2. Identify pharmacologic treatment options for patients with opioid use disorders, and select the best treatment option/s based on patient needs
3. Define at least one way to increase access to treatment for opioid use disorders in the setting(s) or communities where you work as a psychiatric nurse.

Keywords: Opioid, Addiction, Evidence Based Treatments, Opioid Use Disorders, Nursing Practice

Continuing Nursing Education
1.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Originally Presented
APNA 14th Annual Clinical Psychopharmacology Institute
Hyatt Regency Baltimore on the Inner Harbor
Saturday, June 11, 2016
9:45am – 11:15am

Release Date: July 29, 2016
The contact hours for this session expire: September 1, 2019